Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System

Background: Additional surgery after non-curative endoscopic submucosal dissection (ESD) may be excessive as few patients have lymph node metastasis (LNM). It is necessary to develop a risk stratification system for LNM after non-curative ESD, such as the eCura system, which was introduced in the Ja...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sejin Lee, Jeong Ho Song, Sung Hyun Park, Minah Cho, Yoo Min Kim, Hyoung-Il Kim, Woo Jin Hyung
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d62fd0ba0edd4b09a153d458682cab54
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d62fd0ba0edd4b09a153d458682cab54
record_format dspace
spelling oai:doaj.org-article:d62fd0ba0edd4b09a153d458682cab542021-11-25T17:03:46ZDetermination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System10.3390/cancers132257682072-6694https://doaj.org/article/d62fd0ba0edd4b09a153d458682cab542021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5768https://doaj.org/toc/2072-6694Background: Additional surgery after non-curative endoscopic submucosal dissection (ESD) may be excessive as few patients have lymph node metastasis (LNM). It is necessary to develop a risk stratification system for LNM after non-curative ESD, such as the eCura system, which was introduced in the Japanese gastric cancer treatment guidelines. However, the eCura system requires venous and lymphatic invasion to be separately assessed, which is difficult to distinguish without special immunostaining. In this study, we practically modified the eCura system by classifying lymphatic and venous invasion as lymphovascular invasion (LVI). Method: We retrospectively reviewed 543 gastric cancer patients who underwent radical gastrectomy after non-curative ESD between 2006 and 2019. LNM was evaluated according to LVI as well as size >30 mm, submucosal invasion ≥500 µm, and vertical margin involvement, which were used in the eCura system. Results: LNM was present in 8.1% of patients; 3.6%, 2.3%, 7.4%, 18.3%, and 61.5% of patients with no, one, two, three, and four risk factors had LNM, respectively. The LNM rate in the patients with no risk factors (3.6%) was not significantly different from that in patients with one risk factor (2.3%, <i>p</i> = 0.523). Among patients with two risk factors, the LNM rate without LVI was significantly lower than with LVI (2.4% vs. 10.7%, <i>p</i> = 0.027). Among patients with three risk factors, the LNM rate without LVI was lower than with LVI (0% vs. 20.8%, <i>p</i> = 0.195), although not statistically significantly. Based on LNM rates according to risk factors, patients with LVI and other factors were assigned to the high-risk group (LNM, 17.4%) while other patients as a low-risk group (LNM, 2.4%). Conclusions: Modifying the eCura system by classifying lymphatic and venous invasion as LVI successfully stratified LNM risk after non-curative ESD. Moreover, the high-risk group can be simply identified based on LVI and the presence of other risk factors.Sejin LeeJeong Ho SongSung Hyun ParkMinah ChoYoo Min KimHyoung-Il KimWoo Jin HyungMDPI AGarticlenon-curative ESDlymph node metastasiseCura systemNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5768, p 5768 (2021)
institution DOAJ
collection DOAJ
language EN
topic non-curative ESD
lymph node metastasis
eCura system
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle non-curative ESD
lymph node metastasis
eCura system
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Sejin Lee
Jeong Ho Song
Sung Hyun Park
Minah Cho
Yoo Min Kim
Hyoung-Il Kim
Woo Jin Hyung
Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System
description Background: Additional surgery after non-curative endoscopic submucosal dissection (ESD) may be excessive as few patients have lymph node metastasis (LNM). It is necessary to develop a risk stratification system for LNM after non-curative ESD, such as the eCura system, which was introduced in the Japanese gastric cancer treatment guidelines. However, the eCura system requires venous and lymphatic invasion to be separately assessed, which is difficult to distinguish without special immunostaining. In this study, we practically modified the eCura system by classifying lymphatic and venous invasion as lymphovascular invasion (LVI). Method: We retrospectively reviewed 543 gastric cancer patients who underwent radical gastrectomy after non-curative ESD between 2006 and 2019. LNM was evaluated according to LVI as well as size >30 mm, submucosal invasion ≥500 µm, and vertical margin involvement, which were used in the eCura system. Results: LNM was present in 8.1% of patients; 3.6%, 2.3%, 7.4%, 18.3%, and 61.5% of patients with no, one, two, three, and four risk factors had LNM, respectively. The LNM rate in the patients with no risk factors (3.6%) was not significantly different from that in patients with one risk factor (2.3%, <i>p</i> = 0.523). Among patients with two risk factors, the LNM rate without LVI was significantly lower than with LVI (2.4% vs. 10.7%, <i>p</i> = 0.027). Among patients with three risk factors, the LNM rate without LVI was lower than with LVI (0% vs. 20.8%, <i>p</i> = 0.195), although not statistically significantly. Based on LNM rates according to risk factors, patients with LVI and other factors were assigned to the high-risk group (LNM, 17.4%) while other patients as a low-risk group (LNM, 2.4%). Conclusions: Modifying the eCura system by classifying lymphatic and venous invasion as LVI successfully stratified LNM risk after non-curative ESD. Moreover, the high-risk group can be simply identified based on LVI and the presence of other risk factors.
format article
author Sejin Lee
Jeong Ho Song
Sung Hyun Park
Minah Cho
Yoo Min Kim
Hyoung-Il Kim
Woo Jin Hyung
author_facet Sejin Lee
Jeong Ho Song
Sung Hyun Park
Minah Cho
Yoo Min Kim
Hyoung-Il Kim
Woo Jin Hyung
author_sort Sejin Lee
title Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System
title_short Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System
title_full Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System
title_fullStr Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System
title_full_unstemmed Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System
title_sort determination of additional surgery after non-curative endoscopic submucosal dissection in patients with early gastric cancer: a practically modified application of the ecura system
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d62fd0ba0edd4b09a153d458682cab54
work_keys_str_mv AT sejinlee determinationofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectioninpatientswithearlygastriccancerapracticallymodifiedapplicationoftheecurasystem
AT jeonghosong determinationofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectioninpatientswithearlygastriccancerapracticallymodifiedapplicationoftheecurasystem
AT sunghyunpark determinationofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectioninpatientswithearlygastriccancerapracticallymodifiedapplicationoftheecurasystem
AT minahcho determinationofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectioninpatientswithearlygastriccancerapracticallymodifiedapplicationoftheecurasystem
AT yoominkim determinationofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectioninpatientswithearlygastriccancerapracticallymodifiedapplicationoftheecurasystem
AT hyoungilkim determinationofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectioninpatientswithearlygastriccancerapracticallymodifiedapplicationoftheecurasystem
AT woojinhyung determinationofadditionalsurgeryafternoncurativeendoscopicsubmucosaldissectioninpatientswithearlygastriccancerapracticallymodifiedapplicationoftheecurasystem
_version_ 1718412806560153600